The present invention is directed to a method of producing active pharmaceutical ingredients (APIs). The method includes subjecting a reaction mixture with an API precursor to solvent extraction to produce a reactant stream with the API precursor. The method includes concentrating the API precursor in the reactant stream using at least one membrane. The method includes carrying out a reaction in a membrane reactor. The method includes separating the API precursor from the reaction stream using a separator. The method includes crystallizing the API precursor using a crystallizer to produce APIs.

A device and method are described for the treatment of blood, which device may be used in conjunction with or in place of a failed Kidney. The device includes an ultrafiltration unit to remove proteins, red and white blood cells and other high molecular weight components, a nanofiltration unit to remove glucose, at least one electrodeionization unit to transport ions from the blood stream, and a reverse osmosis unit to modulate the flow of water, to both the blood and urine streams. In one embodiment, a specialized electrodeionization unit is provided having multiple chambers defining multiple dilute fluid channels, each channel filled with an ion specific resin wafer, and electrodes at the extremity of the device and proximate each of the resin filled dilute channels. By selective application of voltages to these electrodes, the ion transport functionality of a given dilute channel can be turned on or off.

A device and method are described for the treatment of blood, which device may be used in conjunction with or in place of a failed Kidney. The device includes an ultrafiltration unit to remove proteins, red and white blood cells and other high molecular weight components, a nanofiltration unit to remove glucose, at least one electrodeionization unit to transport ions from the blood stream, and a reverse osmosis unit to modulate the flow of water, to both the blood and urine streams. In one embodiment, a specialized electrodeionization unit is provided having multiple chambers defining multiple dilute fluid channels, each channel filled with an ion specific resin wafer, and electrodes at the extremity of the device and proximate each of the resin filled dilute channels. By selective application of voltages to these electrodes, the ion transport functionality of a given dilute channel can be turned on or off.

The present disclosure relates to an apparatus and an apparatus assembly for assessing the suitability of a membrane, such as an osmotic membrane in an osmotic process. Furthermore, the apparatus, and apparatus assembly provide the means to optimise the parameters of an osmotic process, including the ability to gather key data for different membrane based osmotic systems to enable osmotic process and system optimisation.

The present disclosure relates to an apparatus and an apparatus assembly for assessing the suitability of a membrane, such as an osmotic membrane in an osmotic process. Furthermore, the apparatus, and apparatus assembly provide the means to optimise the parameters of an osmotic process, including the ability to gather key data for different membrane based osmotic systems to enable osmotic process and system optimisation.

The present invention provides a method for hemodiafiltration which applies dialysate gradient across a multi-chambered hemodiafiltrator having a plurality of compartmentalized tubular dialysate chambers. An acidic dialysate with urea at a concentration is applied to a first dialysate chamber. A less acidic dialysate with a lower concentration of urea than those for the first dialysate chamber is applied to a second dialysate chamber. A basic dialysate with no urea but with ammonia at a concentration up to a concentration detected in normal human blood is applied to a last dialysate chamber. The concentrations of urea for the first and second dialysate chambers decrease over time to zero prior to conclusion of hemodiafiltration.

Provided herein is a membrane filter device comprising a cell top cover (A, Y) and a cell bottom cover (B, Z) covering the device, a flexible tube (35, E, F) whereas at the end of the tube, a nozzle jet (22) is also secured via conical reducer to produce upper Reynold's number and for distributing the feed fluid, within the hex hollow chamber (C, X) for storing and receiving feed fluid, a reducer chamber (C, R1, R2) for storing and receiving permeate filtrated fluid, a connector (32, 53, 56) connecting both feed chambers (A, Y, Z) and reducer chambers (A, Y, Z), a membrane assembly (M/F) comprising a layer of membrane (130) sandwiched by a pair of seal rings (P1, OR, P2) and a layer of support net (MS) for securing said membrane (M/F). Most of the joints are connected using threaded joint and flow pressure, therefore no external clamp, nuts or bolts is needed. The flexible tube and the cylindrical shape ensure uniform flow in chambers. The apparatus is therefore a user-friendly and steadfast membrane filter device.

Provided herein is a membrane filter device comprising a cell top cover (A, Y) and a cell bottom cover (B, Z) covering the device, a flexible tube (35, E, F) whereas at the end of the tube, a nozzle jet (22) is also secured via conical reducer to produce upper Reynold's number and for distributing the feed fluid, within the hex hollow chamber (C, X) for storing and receiving feed fluid, a reducer chamber (C, R1, R2) for storing and receiving permeate filtrated fluid, a connector (32, 53, 56) connecting both feed chambers (A, Y, Z) and reducer chambers (A, Y, Z), a membrane assembly (M/F) comprising a layer of membrane (130) sandwiched by a pair of seal rings (P1, OR, P2) and a layer of support net (MS) for securing said membrane (M/F). Most of the joints are connected using threaded joint and flow pressure, therefore no external clamp, nuts or bolts is needed. The flexible tube and the cylindrical shape ensure uniform flow in chambers. The apparatus is therefore a user-friendly and steadfast membrane filter device.

The present invention relates to a method for checking a dialyzer for the presence of a leak in the semipermeable membrane of the dialyzer, wherein the membrane divides the inner dialyzer space into a least one blood chamber and into at least one dialyzate chamber, wherein the blood chamber is flowed through by blood in the operation of the dialyzer and is in fluid communication with a blood-side line system and the vascular system of the patient, and wherein the dialyzate chamber is flowed through by dialysis fluid in the operation of the dialyzer and is in fluid communication with a dialyzate-side line system, wherein the method comprises the following steps: a) emptying the blood chamber or the dialyzate chamber of blood and of dialysis fluid respectively and keeping the fluid (blood or dialyzate) in the non-emptied dialyzate chamber or blood chamber; b) building up a test pressure by means of a gas, in particular by means of air, in the emptied blood chamber or in the emptied dialyzate chamber; and c) measuring the pressure drop over time in the emptied blood chamber or in the emptied dialyzate chamber or in the line system respectively in fluid communication therewith and/or measuring the pressure increase in the non-emptied blood chamber or in the non-emptied dialyzate chamber or in the line system respectively in fluid communication therewith or measuring the number of air bubbles or of a parameter correlated with the number of air bubbles in the non-emptied blood chamber or in the non-emptied dialyzate chamber or in a line system respectively in fluid communication therewith,
wherein the steps a) to c) are carried out subsequent to the blood treatment of the patient and subsequent to the disconnection of the patient from the blood-side line system.

The present invention relates to a method for checking a dialyzer for the presence of a leak in the semipermeable membrane of the dialyzer, wherein the membrane divides the inner dialyzer space into a least one blood chamber and into at least one dialyzate chamber, wherein the blood chamber is flowed through by blood in the operation of the dialyzer and is in fluid communication with a blood-side line system and the vascular system of the patient, and wherein the dialyzate chamber is flowed through by dialysis fluid in the operation of the dialyzer and is in fluid communication with a dialyzate-side line system, wherein the method comprises the following steps: a) emptying the blood chamber or the dialyzate chamber of blood and of dialysis fluid respectively and keeping the fluid (blood or dialyzate) in the non-emptied dialyzate chamber or blood chamber; b) building up a test pressure by means of a gas, in particular by means of air, in the emptied blood chamber or in the emptied dialyzate chamber; and c) measuring the pressure drop over time in the emptied blood chamber or in the emptied dialyzate chamber or in the line system respectively in fluid communication therewith and/or measuring the pressure increase in the non-emptied blood chamber or in the non-emptied dialyzate chamber or in the line system respectively in fluid communication therewith or measuring the number of air bubbles or of a parameter correlated with the number of air bubbles in the non-emptied blood chamber or in the non-emptied dialyzate chamber or in a line system respectively in fluid communication therewith,
wherein the steps a) to c) are carried out subsequent to the blood treatment of the patient and subsequent to the disconnection of the patient from the blood-side line system.